Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21550Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Papatheodorou, S. I. | en |
| dc.contributor.author | Evangelou, E. | en |
| dc.contributor.author | Makrydimas, G. | en |
| dc.contributor.author | Ioannidis, J. P. | en |
| dc.date.accessioned | 2015-11-24T19:15:43Z | - |
| dc.date.available | 2015-11-24T19:15:43Z | - |
| dc.identifier.issn | 1471-0528 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21550 | - |
| dc.rights | Default Licence | - |
| dc.subject | Female | en |
| dc.subject | Fetal Heart/abnormalities/*ultrasonography | en |
| dc.subject | Heart Defects, Congenital/embryology/*ultrasonography | en |
| dc.subject | Humans | en |
| dc.subject | Nuchal Translucency Measurement | en |
| dc.subject | Pregnancy | en |
| dc.subject | Pregnancy Trimester, First | en |
| dc.subject | Sensitivity and Specificity | en |
| dc.subject | *Ultrasonography, Prenatal | en |
| dc.title | First-trimester ductus venosus screening for cardiac defects: a meta-analysis | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1111/j.1471-0528.2011.03029.x | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21668765 | - |
| heal.identifier.secondary | http://onlinelibrary.wiley.com/store/10.1111/j.1471-0528.2011.03029.x/asset/j.1471-0528.2011.03029.x.pdf?v=1&t=h0l47h33&s=705dc5c0b84308ad3f25b0db2bc4fa174a8e7b05 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2011 | - |
| heal.abstract | BACKGROUND: Heart defects are the most common congenital abnormalities. OBJECTIVE: We aimed to evaluate in a meta-analysis the screening performance of abnormal ductus venosus (DV) Doppler waveform for detection of congenital heart disease (CHD) in chromosomally normal fetuses. SEARCH STRATEGY: Studies were retrieved from a search of MEDLINE, ISI, SCOPUS and EMBASE (from 1999 to March 2011) using the keywords 'ductus venosus', 'DV', 'chromosomal abnormalities', 'congenital heart disease' and 'nuchal translucency'. SELECTION CRITERIA: We considered all studies that examined the diagnostic performance of DV in the first trimester for CHD in chromosomally normal fetuses. We included studies that were limited to fetuses with increased nuchal translucency (NT), normal NT, and studies that examined fetuses regardless of NT status. DATA COLLECTION AND ANALYSIS: Seven studies (n = 50,354) regardless of the NT status, nine studies (n = 2908) with increased NT and seven studies (n = 47,610) with normal NT were included in the meta-analysis. We drew hierarchical summary receiver operating characteristic (HSROC) curves using the parameters of the fitted models. MAIN RESULTS: In populations including participants regardless of NT status, the summary sensitivity and specificity of DV for detecting CHD were 50 and 93%, respectively. In participants with increased NT, the summary sensitivity and specificity were 83 and 80%, and in those with normal NT, they were 19 and 96%, respectively. AUTHORS' CONCLUSIONS: The estimated performance of DV assessment for detection of CHD in chromosomally normal fetuses can be considered in evaluating the potential use and limitations of this screening test. | en |
| heal.journalName | BJOG | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Papatheodorou-2011-First-trimester duct.pdf | 199.8 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
